Actively Recruiting
Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation
Led by Superior University · Updated on 2026-04-15
60
Participants Needed
1
Research Sites
70 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled trial aims to compare the effectiveness of a Collaborative Virtual Reality Environment (CVE) and Non-Immersive Virtual Reality (NIVR) in the rehabilitation of patients with Parkinson's disease. Participants with mild to moderate disease severity will be randomly assigned to either the CVE group or the NIVR group. The CVE intervention will involve therapist-guided, interactive virtual exercises in a shared environment, promoting real-time engagement and feedback. The NIVR group will perform task-oriented exercises using screen-based virtual reality without immersive and collaborative features. Both interventions will be delivered over an 12-week period. Primary outcomes will assess motor function using standardized clinical scales, while secondary outcomes will evaluate cognitive function, mobility, and quality of life. The study seeks to determine whether collaborative and interactive virtual rehabilitation provides superior clinical outcomes compared to conventional non-immersive virtual approaches in patients with Parkinson's disease.
CONDITIONS
Official Title
Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and Female
- Age between 45 and 80 years
- Diagnosed with idiopathic Parkinson's disease with mild to moderate severity (Hoehn & Yahr stages I-III)
- Currently on conventional and stable medical treatment
- No severe cognitive impairments (MMSE score of 24 or higher)
- Able to participate in virtual rehabilitation sessions
- Willing to participate and provide informed consent
You will not qualify if you...
- Severe visual, auditory, or motor impairments unrelated to Parkinson's disease
- Fear of virtual environments
- Comorbidities that prevent participation (e.g., advanced dementia)
- Severe musculoskeletal conditions limiting movement
- History of epilepsy or other contraindications for virtual reality exposure
- Participation in another interventional study within the past 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Punjab Institute of Neurosciences Lahore
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
Research Team
H
Hafiz Muddassir Riaz
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here